-

INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Reminds Investors of a Securities Class Action Against Frequency, Inc. (NASDAQ: FREQ)

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international shareholder and consumer rights litigation firm, reminds investors of a securities class action lawsuit against Frequency, Inc. (NASDAQ: FREQ) (“Frequency” or the “Company”) and its Chief Executive Officer, David Lucchino, alleging violations of §§10(b) and 20(a) of the Securities Exchange Act (15 U.S.C. §§78j(b) and 78t(a)) and Rule 10b-5 promulgated thereunder (17 C.F.R. §240.10b-5). If you purchased Frequency common stock between November 16, 2020, and March 22, 2021, inclusive (the “Class Period”), and have suffered a loss, realized or unrealized, you are encouraged to contact Joe Pettigrew for additional information at 844-818-6982 or jpettigrew@scott-scott.com.

Frequency is a pharmaceutical company focused on the development and commercialization of a hearing loss treatment titled “FX-322,” which the Company has long promoted as a potential treatment for patients with severe sensorineural hearing loss (“SNHL”).

The complaint alleges that Frequency and CEO Lucchino misled investors about the Phase 2a study of FX-322.

Before the market opened on March 23, 2021, Frequency disclosed in a press release disappointing interim results of the Phase 2a study, revealing that subjects with mild to moderate SNHL did not demonstrate improvements in hearing measures versus placebo.

On this news, Frequency’s shares fell from $36.29 to $7.99, a 78% drop, damaging investors.

Lead Plaintiff Deadline

The Lead Plaintiff deadline in this action is August 2, 2021. Any member of the proposed Class may seek to serve as Lead Plaintiff through counsel of their choice, or may choose to do nothing and remain a member of the proposed Class.

What You Can Do

If you purchased Frequency common stock between November 16, 2020, and March 22, 2021, or if you have questions about this notice or your legal rights, you are encouraged to contact attorney Joe Pettigrew at 844-818-6982 or jpettigrew@scott-scott.com.

About Scott+Scott

Scott+Scott has significant experience in prosecuting major securities, antitrust, and consumer rights actions throughout the United States. The firm represents pension funds, foundations, individuals, and other entities worldwide with offices in New York, London, Amsterdam, Connecticut, California, Virginia, and Ohio.

This may be considered Attorney Advertising.

Contacts

Joe Pettigrew
Scott+Scott Attorneys at Law LLP
230 Park Avenue, 17th Floor, New York, NY 10169
844-818-6982
jpettigrew@scott-scott.com

Scott+Scott Attorneys at Law LLP

NASDAQ:FREQ

Release Summary
REMINDER: Scott+Scott Attorneys at Law LLP Reminds Investors of a Securities Class Action Against Frequency, Inc. (NASDAQ: FREQ)
Release Versions

Contacts

Joe Pettigrew
Scott+Scott Attorneys at Law LLP
230 Park Avenue, 17th Floor, New York, NY 10169
844-818-6982
jpettigrew@scott-scott.com

More News From Scott+Scott Attorneys at Law LLP

UTZ BRANDS, INC. INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Utz Brands, Inc.’s Directors and Officers for Breach of Fiduciary Duties – UTZ

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP has launched an urgent investigation into whether certain officers and directors of Utz Brands, Inc. (NYSE: UTZ) approved a buyout of Utz for inadequate consideration, breaching their fiduciary duties to Utz’s shareholders, and whether Utz’s shareholders have suffered damages as a result. Attorney Joseph A. Pettigrew is heading the investigation—what shareholders need to know: On July 21, 2026, Utz announced it had reached an agreement...

CHEMED CORPORATION INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Chemed Corporation’s Directors and Officers for Breach of Fiduciary Duties – CHE

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP has launched an urgent investigation into whether certain officers and directors of Chemed Corporation (NYSE: CHE) failed to manage Chemed in an acceptable manner, breaching their fiduciary duties to Chemed, and whether Chemed and its shareholders have suffered damages as a result. Attorney Joseph A. Pettigrew is heading the investigation—what shareholders need to know: On August 13, 2026, The Capital Forum released a report alleging t...

L3HARRIS TECHNOLOGIES, INC. INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates L3Harris Technologies, Inc.’s Directors and Officers for Breach of Fiduciary Duties – LHX

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP has launched an urgent investigation into whether certain officers and directors of L3Harris Technologies, Inc. (NYSE: LHX) failed to manage L3Harris in an acceptable manner, breaching their fiduciary duties to L3Harris, and whether L3Harris and its shareholders have suffered damages as a result. Attorney Joseph A. Pettigrew is heading the investigation—what shareholders need to know:On August 17, 2026, L3Harris announced it had entered...
Back to Newsroom